Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and array-based technologies, today announced a collaboration with Broad Clinical Labs to rapidly streamline and scale ...

Wolfe Research reiterated an Outperform rating and $150 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about ...

“The small RNA sequencing was going to take a lot of customization ... Download the new Introduction to Next-Generation Sequencing ebook from Illumina to learn more. You might also be interested in ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of | Roche said ...

Now, although traditional RNA sequencing has played an instrumental ... the BD Rhapsody system, and Illumina sequencing technologies. Next, the researchers discuss the multiple steps involved ...

RBC Capital reiterated an Outperform rating and $247 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about its ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

In the first presentation of this GEN webinar, our expert speaker Devansh Agarwal will present results from a study and how the scientists generated RGC-like induced neurons in under a week by ...

Illumina, Inc. offers sequencing- and array-based solutions ... specific genes, and RNA or other genomic regions of interest.